Condition: Cerebral Small Vessel Diseases · Inflammation · Stroke · Sponsor: University of Cambridge
A prospective observational cohort study in patients with cerebral small vessel disease deterring whether changes in systemic inflammation predict brain white matter damage measured using MRI and cognitive decline. This is a study funded by a joint BHF-Dutch Heart Foundation research grant and will be conducted in both Cambridge UK and Nijmegen Netherlands with 100 of the 200 total participants recruited at each site, and data from both sites analysed together.
This description comes directly from the study's public registry record.
Hugh S Markus · +44 (0)1223 856661 · hsm32@medschl.cam.ac.uk
Audrey Low · +44 (0) 1223 216619 · al927@medschl.cam.ac.uk
Always discuss trial participation with your own doctor first.
| Radboud University Medical Centre | Nijmegen, Netherlands | Recruiting |
| University of Cambridge | Cambridge, Cambridgeshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05746221